Skystar Bio-Pharmaceutical Co (NASDAQ:SKBI)

Data as of Jan 30
 -0.14 / -3.23%
Today’s Change
Today|||52-Week Range
Health Technology

Company Description

Skystar Bio-Pharmaceutical Co. is a holding company that engages in the research, development, production, distribution, and sale of veterinary healthcare and medical care products. It operates through the following product lines: micro-organism, veterinary medicine, feed additives, and bio-pharmaceutical veterinary vaccine. The company was founded in 1997 and is headquartered in Xi'an, China.

Contact Information

Skystar Bio-Pharmaceutical Co.
4/F Building B, Chuangye Square
Xi'an Shaanxi 710000
Investor Relations:
(629) 645-4433



Individual stakeholders31.61%
Other institutional14.60%
Mutual fund holders0.49%

Top Executives

Wei Bing LuChairman & Chief Executive Officer
Bing MeiCFO & Principal Accounting Officer
R. Scott CramerNon-Executive Director & IR Contact
Wei WenSecretary & Director

Most stock quote data provided by BATS. Market indices are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer.

Morningstar: © 2015 Morningstar, Inc. All Rights Reserved.

Factset: FactSet Research Systems Inc. 2015. All rights reserved.

Chicago Mercantile Association: Certain market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved.

Dow Jones: The Dow Jones branded indices are proprietary to and are calculated, distributed and marketed by DJI Opco, a subsidiary of S&P Dow Jones Indices LLC and have been licensed for use to S&P Opco, LLC and CNN. Standard & Poor's and S&P are registered trademarks of Standard & Poor’s Financial Services LLC and Dow Jones is a registered trademark of Dow Jones Trademark Holdings LLC. All content of the Dow Jones branded indices © S&P Dow Jones Indices LLC 2015 and/or its affiliates.